Company news
Phc Holdings Corp. (TSE:6523) news
Every Phc Holdings Corp. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Notice Concerning Change of Major Shareholder
September 2, 2026
Consolidated Financial Results for the Three Months Ended June 30, 2026 [IFRS]
August 6, 2026
PHC Launches Cell-IQ CO2 Incubators with Active Humidity Control, Creating Critical Stability for Research Samples
June 19, 2026
PHC Launches Cell-IQ® CO₂ Incubators with Active Humidity Control, Creating Critical Stability for Research Samples
June 18, 2026
Matters Concerning Controlling Shareholders, etc.
June 12, 2026
Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience
June 1, 2026
PHCbi Launches LiCellGrow™ Cell Expansion System to Support High-Quality and Efficient Production of Cell and Gene Therapies
March 2, 2026
Ascensia Diabetes Care Appoints Peter Bodlund as President and Chief Executive Officer
February 25, 2026
Epredia and Mindpeak Announce EU Distribution Agreement for AI-Powered Image Recognition in Cancer Diagnostics
February 24, 2026
PHC Corporation of North America Launches TwinGuard ECO 703VXH Freezer, Bringing New Energy Efficiency to Research Sample Protection
January 16, 2026
PHC Corporation of North America Launches TwinGuard® ECO 703VXH Freezer, Bringing New Energy Efficiency to Research Sample Protection
January 15, 2026
Ascensia Honors Real Stories and Emotional Truths With Winners of the 2025 "This Is Diabetes. This Is Anxiety." Global Art Campaign.
November 14, 2025
PHC Group Announces Integration of Subsidiaries Wemex Corporation and Wemex Healthcare Systems Corporation to Accelerate Response to Evolving Healthcare IT Needs in Japan
October 1, 2025
Epredia’s E1000 Dx Digital Pathology Solution Wins 2025 International Scanner Benchmark Awards from the Ecosystem for Pathology Diagnostics with AI Assistance (EMPAIA)
September 29, 2025
Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics
September 3, 2025
PHC Corporation's Biomedical Division Wins 2025 R&D 100 Award for LiCellMo Live Cell Metabolic Pathway Analyzer
September 1, 2025
PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan
July 1, 2025
PHC and Cyfuse Develop Innovative Production Technology for the Commercialization of 3D Cell Products
March 20, 2025
PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality
February 10, 2025
PHC Live Cell Metabolic Analyzer (LiCellMo) Receives 2024 Innovation Award from The Analytical Scientist
December 13, 2024
PHC Group Named a Top 100 Healthcare Technology Company of 2024 by The Healthcare Technology Report
November 22, 2024
PHC Group Releases Value Creation Plan 2027, Outlining Measures to Achieve New Vision
November 14, 2024
PHC Unveils Prototype of LiCellGrow, New Cell Expansion System to Support Development of Cell and Gene Therapy Products Manufacturing Process
September 2, 2024
Notice Concerning Cancellation of ISO 15189 Accreditation of Central Laboratory at LSI Medience Corporation, a Subsidiary of PHC Holdings Corporation
July 29, 2024